Communiqués SSY Group Limited

Actions

2005

KYG8406X1034

Produits pharmaceutiques

Temps Différé Hong Kong S.E. 05:59:09 10/09/2026			Varia. 5j.	Varia. 1 janv.
2,590 ^HKD	-1,89%		-5,30%	-8,48%

02/09	Le traitement de l'angine de poitrine de SSY Group franchit l'évaluation de conformité du régulateur chinois	MT
02/09	SSY Group Limited obtient l'approbation de l'évaluation de la cohérence pour ses comprimés de chlorhydrate de diltiazem	CI

Communiqués

28/07/21	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT	PU
03/05/21	SSY : Proxy Form for Extraordinary General Meeting	PU
03/05/21	SSY : (1) CONTINUING CONNECTED TRANSACTIONS - MASTER SALE AND PURCHASE AGREEMENT AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING	PU
03/05/21	SSY : NOTICE OF EXTRAORDINARY GENERAL MEETING	PU
30/04/21	SSY : UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2021	PU
20/04/21	SSY : PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS, DECLARATION OF FINAL DIVIDEND AND NOTICE OF ANNUAL GENERAL MEETING	PU
20/04/21	SSY : Proxy Form for Annual General Meeting 2021	PU
14/04/21	SSY : CONTINUING CONNECTED TRANSACTIONS - MASTER SALE AND PURCHASE AGREEMENT	PU
12/04/21	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT	PU
25/03/21	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT	PU
18/09/20	SSY : Next Day Disclosure Return	PU
16/09/20	SSY : Next Day Disclosure Return	PU
14/09/20	SSY : Next Day Disclosure Return	PU
10/09/20	SSY : Next Day Disclosure Return	PU
21/08/20	SSY : VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT	PU
19/08/20	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT AND PRODUCT DEVELOPMENT	PU
29/07/20	SSY : VOLUNTARY ANNOUNCEMENT - INTRA-GROUP RESTRUCTURING FOR POSSIBLE SPIN-OFF AND SEPARATE LISTING	PU
24/02/20	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT	PU
20/02/20	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT	PU
19/02/20	SSY : INSIDE INFORMATION - Inclusion of Abidol in Diagnosis and Treatment Program for Novel Coronavirus Infected Pneumonia (Trial Version 6)	PU
06/02/20	SSY : VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT	PU
06/02/20	SSY : EXCHANGE NOTICE - RESUMPTION OF TRADING	PU
05/02/20	SSY : INSIDE INFORMATION, UNUSUAL TRADING VOLUME AND PRICE MOVEMENTS, RESUMPTION OF TRADING	PU
05/02/20	SSY : TRADING HALT	PU
05/02/20	SSY : EXCHANGE NOTICE - TRADING HALT	PU